Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis

Antonella Tosti, Bianca Maria Piraccini, Massimiliano Pazzaglia, Colombina Vincenzi

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Background: Efficacy of topical steroids in alopecia areata is still discussed. Objective: The purpose of this study was to evaluate the efficacy of clobetasol propionate 0.05% ointment under occlusion in 28 patients with alopecia areata totalis (AT) or AT/alopecia universalis. Methods: A total of 28 patients were instructed to apply 2.5 g of clobetasol propionate to the right side of the scalp every night under occlusion with a plastic film. Treatment was performed 6 days a week for 6 months. When regrowth of terminal hair occurred, treatment was extended over the entire scalp. All patients were followed up for another 6 months. Results: Of the 28 patients included in the study, 8 were treated successfully (28.5%). Regrowth of terminal hair began on the treated side 6 to 14 weeks after the start of treatment. Of these 8 patients, 3 had a relapse and were not able to maintain hair regrowth. Conclusion: Our study shows that clobetasol propionate 0.05% under occlusion is effective in inducing hair regrowth in patients with AT or AT/alopecia universalis. Occurrence of hair regrowth only on the treated half of the scalp clearly shows that efficacy of treatment is a result of a local and not systemic effect of the drug. Although only 17.8% of patients had long-term benefit by treatment, our results were obtained in a population of patients with severe and refractory forms of the disease.

Original languageEnglish
Pages (from-to)96-98
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume49
Issue number1
DOIs
StatePublished - Jul 1 2003
Externally publishedYes

Fingerprint

Clobetasol
Hair
Scalp
Alopecia Areata
Therapeutics
Alopecia universalis
Ointments
Plastics
Steroids
Recurrence

ASJC Scopus subject areas

  • Dermatology

Cite this

Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. / Tosti, Antonella; Piraccini, Bianca Maria; Pazzaglia, Massimiliano; Vincenzi, Colombina.

In: Journal of the American Academy of Dermatology, Vol. 49, No. 1, 01.07.2003, p. 96-98.

Research output: Contribution to journalArticle

Tosti, Antonella ; Piraccini, Bianca Maria ; Pazzaglia, Massimiliano ; Vincenzi, Colombina. / Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. In: Journal of the American Academy of Dermatology. 2003 ; Vol. 49, No. 1. pp. 96-98.
@article{c2200e9116c24e179d4f59335a8792e4,
title = "Clobetasol propionate 0.05{\%} under occlusion in the treatment of alopecia totalis/universalis",
abstract = "Background: Efficacy of topical steroids in alopecia areata is still discussed. Objective: The purpose of this study was to evaluate the efficacy of clobetasol propionate 0.05{\%} ointment under occlusion in 28 patients with alopecia areata totalis (AT) or AT/alopecia universalis. Methods: A total of 28 patients were instructed to apply 2.5 g of clobetasol propionate to the right side of the scalp every night under occlusion with a plastic film. Treatment was performed 6 days a week for 6 months. When regrowth of terminal hair occurred, treatment was extended over the entire scalp. All patients were followed up for another 6 months. Results: Of the 28 patients included in the study, 8 were treated successfully (28.5{\%}). Regrowth of terminal hair began on the treated side 6 to 14 weeks after the start of treatment. Of these 8 patients, 3 had a relapse and were not able to maintain hair regrowth. Conclusion: Our study shows that clobetasol propionate 0.05{\%} under occlusion is effective in inducing hair regrowth in patients with AT or AT/alopecia universalis. Occurrence of hair regrowth only on the treated half of the scalp clearly shows that efficacy of treatment is a result of a local and not systemic effect of the drug. Although only 17.8{\%} of patients had long-term benefit by treatment, our results were obtained in a population of patients with severe and refractory forms of the disease.",
author = "Antonella Tosti and Piraccini, {Bianca Maria} and Massimiliano Pazzaglia and Colombina Vincenzi",
year = "2003",
month = "7",
day = "1",
doi = "10.1067/mjd.2003.423",
language = "English",
volume = "49",
pages = "96--98",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis

AU - Tosti, Antonella

AU - Piraccini, Bianca Maria

AU - Pazzaglia, Massimiliano

AU - Vincenzi, Colombina

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Background: Efficacy of topical steroids in alopecia areata is still discussed. Objective: The purpose of this study was to evaluate the efficacy of clobetasol propionate 0.05% ointment under occlusion in 28 patients with alopecia areata totalis (AT) or AT/alopecia universalis. Methods: A total of 28 patients were instructed to apply 2.5 g of clobetasol propionate to the right side of the scalp every night under occlusion with a plastic film. Treatment was performed 6 days a week for 6 months. When regrowth of terminal hair occurred, treatment was extended over the entire scalp. All patients were followed up for another 6 months. Results: Of the 28 patients included in the study, 8 were treated successfully (28.5%). Regrowth of terminal hair began on the treated side 6 to 14 weeks after the start of treatment. Of these 8 patients, 3 had a relapse and were not able to maintain hair regrowth. Conclusion: Our study shows that clobetasol propionate 0.05% under occlusion is effective in inducing hair regrowth in patients with AT or AT/alopecia universalis. Occurrence of hair regrowth only on the treated half of the scalp clearly shows that efficacy of treatment is a result of a local and not systemic effect of the drug. Although only 17.8% of patients had long-term benefit by treatment, our results were obtained in a population of patients with severe and refractory forms of the disease.

AB - Background: Efficacy of topical steroids in alopecia areata is still discussed. Objective: The purpose of this study was to evaluate the efficacy of clobetasol propionate 0.05% ointment under occlusion in 28 patients with alopecia areata totalis (AT) or AT/alopecia universalis. Methods: A total of 28 patients were instructed to apply 2.5 g of clobetasol propionate to the right side of the scalp every night under occlusion with a plastic film. Treatment was performed 6 days a week for 6 months. When regrowth of terminal hair occurred, treatment was extended over the entire scalp. All patients were followed up for another 6 months. Results: Of the 28 patients included in the study, 8 were treated successfully (28.5%). Regrowth of terminal hair began on the treated side 6 to 14 weeks after the start of treatment. Of these 8 patients, 3 had a relapse and were not able to maintain hair regrowth. Conclusion: Our study shows that clobetasol propionate 0.05% under occlusion is effective in inducing hair regrowth in patients with AT or AT/alopecia universalis. Occurrence of hair regrowth only on the treated half of the scalp clearly shows that efficacy of treatment is a result of a local and not systemic effect of the drug. Although only 17.8% of patients had long-term benefit by treatment, our results were obtained in a population of patients with severe and refractory forms of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0037710129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037710129&partnerID=8YFLogxK

U2 - 10.1067/mjd.2003.423

DO - 10.1067/mjd.2003.423

M3 - Article

C2 - 12833016

AN - SCOPUS:0037710129

VL - 49

SP - 96

EP - 98

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 1

ER -